跳至主要内容
临床试验/SLCTR/2024/006
SLCTR/2024/006尚未招募3 期

Standardization of Kalingathyennai and evaluation of its effectiveness in sub-fertile women with Polycystic Ovary Syndrome (Soothaga Vaayu)

nit of Siddha Medicine, Faculty of Applied Science0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Subfertile women between 20 to 45 years with PCOS. (Subfertility defined as - Inability to conceive after 1year of regular unprotected intercourse)
  • 2. PCOS will be diagnosed according to the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2018. Monash University: Melbourne, Australia; Sonographic appearance of polycystic ovaries and one of the following criteria: Infrequent cycles (formerly referred to as oligomenorrhoea) or amenorrhoea; hyperandrogenism (clinical or laboratory).
  • 3. Women who have been under any form of treatment (Allopathic or Siddha or Ayurvedic or Unani or Homeopathic or Traditional Chinese) for PCOS or subfertility within the three previous months will be recruited after three months (washout time) without taking any medication for PCOS or subfertility.

排除标准

  • 1.Women with inherited disorders such as Cushing syndrome, hyperprolactinemia, untreated hypothyroidism, congenital adrenal hyperplasia, or with an androgen-secreting ovarian/adrenal tumour and those taking a corticosteroid, antiepileptic or antipsychotic drugs.
  • 2.Women who are not suitable for pregnancy (Uncontrolled Diabetic Mellitus, Uncontrolled Hypertension, etc) and women with Body Mass Index >30.
  • 3.Women with tubal factor infertility and women whose partners have azoospermia.

研究者

发起方
nit of Siddha Medicine, Faculty of Applied Science

相似试验

Placebo controlled Randomized Clinical Trial to... | 临床试验